In abortion pill case, US high court may undermine drug regulator

The US Supreme Court is set to hear a crucial case regarding the availability of abortion pills, with potential implications for the authority of the FDA. The case focuses on mifepristone, a key medication for abortions, but a broad decision could impact access to various other drugs. Mifepristone, approved by the FDA in 2000, is widely used in the US and deemed safe globally.